BREAST CANCER STAGE IV
Clinical trials for BREAST CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER STAGE IV trials appear
Sign up with your email to follow new studies for BREAST CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood Test-Guided therapy aims to cure advanced breast cancer
⭐️ CURE ⭐️ Recruiting nowThis study is testing whether a personalized treatment approach can lead to long-term remission or cure for people with advanced HER2-positive breast cancer. Researchers will use regular blood tests to guide treatment decisions, adjusting therapies based on cancer activity while …
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: ⭐️ CURE ⭐️
Last updated Mar 16, 2026 15:27 UTC
-
New hope for breast cancer patients with brain tumors
Disease control Recruiting nowThis study is testing whether a drug called datopotamab-deruxtecan can shrink breast cancer tumors that have spread to the brain. It's for people with a hard-to-treat type called triple-negative breast cancer who have new or growing brain metastases. The main goal is to see how w…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo attack on spreading breast cancer
Disease control Recruiting nowThis early-stage study aims to find the safest and most effective dose of the drug abemaciclib when given at the same time as targeted radiation therapy. It is for people with advanced, hormone-sensitive breast cancer that has spread to the bones. The goal is to see if this combi…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New pill targets Tough-to-Treat breast cancer in groundbreaking trial
Disease control Recruiting nowThis study is testing a new oral drug called FWD1802 for women with a specific type of advanced breast cancer (ER+/HER2-) that has spread or cannot be surgically removed. The first part of the trial aims to find a safe and effective dose. The second part will see how well the dru…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Radical stem cell combo aims to outsmart tough cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment for people with metastatic pancreatic or breast cancer. The goal is to see if a combination of high-dose chemotherapy drugs, vitamins, and the patient's own stem cells is safe and can overcome the cancer's resistance to treatment.…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Smartphone app trial aims to tame side effects for advanced breast cancer treatment
Disease control Recruiting nowThis study is testing a two-drug combination (T-DXd and pertuzumab) as the first treatment for people with advanced HER2-positive breast cancer that has spread. It aims to see how well the treatment works and how it affects quality of life, while using a special smartphone app, a…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New scan could pinpoint best drug for tough breast cancers
Diagnosis Recruiting nowThis study is testing a new type of PET scan to see if it can better identify which patients with advanced breast cancer are likely to benefit from a specific targeted drug called T-DXd. The scan looks for a protein called HER2 on cancer cells. Researchers hope this more precise …
Matched conditions: BREAST CANCER STAGE IV
Sponsor: Renske Altena • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
Cherry juice trial aims to shield cancer patients from Chemo's painful side effect
Symptom relief Recruiting nowThis study is testing whether drinking tart cherry juice can prevent nerve pain (neuropathy) caused by a common chemotherapy drug called paclitaxel. It will enroll 86 people with breast or ovarian cancer who are starting this type of chemo. Participants will be randomly assigned …
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC